Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
CalciMedica ( (CALC) ) has issued an announcement.
On January 10, 2025, Eric Bjerkholt resigned from the board of directors and audit committee of CalciMedica, Inc., effective January 15, 2025. His resignation was not due to any disagreements with the company. On January 13, 2025, the board appointed Alan Glicklich, M.D., as a Class I director, effective January 15, 2025, with his term expiring in 2027. Dr. Glicklich’s appointment involves no special arrangements, and he will receive an annual cash retainer and stock options as per company policy.
More about CalciMedica
YTD Price Performance: -11.85%
Average Trading Volume: 62,383
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $40.72M
See more insights into CALC stock on TipRanks’ Stock Analysis page.
